Vijay Chiruvolu
Chief Tech/Sci/R&D Officer at TURNSTONE BIOLOGICS CORP.
Net worth: - $ as of 2024-04-29
Vijay Chiruvolu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Chief Tech/Sci/R&D Officer | 2023-02-28 | - |
Career history of Vijay Chiruvolu
Former positions of Vijay Chiruvolu
| Companies | Position | Start | End |
|---|---|---|---|
| INSTIL BIO, INC. | Chief Tech/Sci/R&D Officer | 2020-06-30 | 2022-09-01 |
| KITE PHARMA INC | Corporate Officer/Principal | - | - |
Training of Vijay Chiruvolu
| The University of Nebraska-Lincoln | Doctorate Degree |
| The Pennsylvania State University | Masters Business Admin |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Vijay Chiruvolu
- Experience